HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECGGlobeNewsWire • 04/24/24
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative PatientsGlobeNewsWire • 03/26/24
HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 DiabetesGlobeNewsWire • 03/12/24
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet TechnologyGlobeNewsWire • 03/06/24
HeartSciences Announces Results and Adjournment of Annual Shareholder MeetingGlobeNewsWire • 01/18/24
HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder MeetingGlobeNewsWire • 01/03/24
HeartSciences' MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police OfficersGlobeNewsWire • 11/13/23
Top 5 Health Care Stocks That Are Preparing To Pump In November - Better Therapeutics (NASDAQ:BTTX), Arcutis Biotherapeutics (NASDAQ:ARQT)Benzinga • 11/03/23
HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence AwardsGlobeNewsWire • 09/11/23
HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, IndiaGlobeNewsWire • 09/07/23